The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if on one end of the spectrum you have MDMA which again I don't consider a classical psychedelic but as a tool that can be applied to some of the same conditions what makes MDMA attractive is general low toxicity relative ease of administration short duration if we're looking at I want to say four to six hours let's say maybe a little bit longer 48 hours ibogaine falls on the opposite end of the spectrum
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.